Microbot Medical Inc.

NasdaqCM MBOT

Microbot Medical Inc. Free Cash Flow Yield on February 06, 2025

Microbot Medical Inc. Free Cash Flow Yield is NA on February 06, 2025, a NA change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Microbot Medical Inc. 52-week high Free Cash Flow Yield is -13.03% on January 06, 2025, which is NA below the current Free Cash Flow Yield.
Microbot Medical Inc. 52-week low Free Cash Flow Yield is -41.93% on October 01, 2024, which is NA below the current Free Cash Flow Yield.
Microbot Medical Inc. average Free Cash Flow Yield for the last 52 weeks is -34.58%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NasdaqCM: MBOT

Microbot Medical Inc.

CEO	Mr. Harel Gadot
IPO Date	March 25, 1992
Location	United States
Headquarters	25 Recreation Park Drive
Employees	21
Sector	Technology
Industries Robotics 3D Printing Medical Instruments

Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Key trends

Past 5 years